Inflammatory increase in T cell activation and cytokine release proliferation promotes Th1 response increases NK cell activation Increases macrophage activation and cytokine release (TNF-a/IL-6 etc.) Activates neutrophils and increases their chemotaxis and oxidative burst Prevents inflammatory damage in conditions of overt immune system stimulation
Induces endothelial dysfunction Increases blood pressure Atherosclerosis Increases ICAM and VCAM Plasma levels related to hard clinical endpoints but acutely releases NO from endothelium
Adiponectin
Anti-inflammatory Decreases T cell activation and proliferation Inhibits NF-κB dependent cytokine release and adhesion molecule expression (including TNF-a/IL-6) Increases IL-10 Inhibits phagocytosis and oxidative burst
Vasculoprotective Prevents atherosclerosis Is decreased in hypertension Correlated with HDL and inversely with LDL Plasma levels not related to hard endpoints
Pathogenic Impairs bradykinin dependent vasorelaxations (NO and EDHF) No effect on acetylcholine dependent vasorelaxations (NO) VEGF and MMP up regulation